The half-life of tramadol is increased by which condition?

A. Hypertension: High blood pressure does not significantly alter the pharmacokinetics of tramadol. While hypertension may affect overall cardiovascular health, it does not impact drug metabolism or excretion pathways in a way that prolongs the half-life of tramadol. B. Asthma: Respiratory conditions like asthma primarily affect lung function and oxygenation. Tramadol is metabolized hepatically and excreted renally, so asthma does not directly influence its half-life. C. Anxiety: Psychological conditions such as anxiety do not modify tramadol’s pharmacokinetics. Anxiety may influence perception of pain or side effects but does not prolong drug clearance. D. Renal impairment: Tramadol and its active metabolites are excreted primarily by the kidneys. Impaired renal function decreases drug clearance, resulting in accumulation and an increased half-life. This prolongation raises the risk for adverse effects, including central nervous system depression and respiratory compromise.